Twin Capital Management Inc Pfizer Inc Transaction History

Twin Capital Management Inc

$827 Million
Q2 2024

A detailed history of Twin Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Twin Capital Management Inc holds 20,692 shares of PFE stock, worth $613,724. This represents 0.07% of its overall portfolio holdings.

Number of Shares

20,692

Previous 20,892 0.96%

Holding current value

$613,724

Previous $579,000 0.17%

% of portfolio

0.07%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $5,052 - $5,920	-200 Reduced 0.96%	20,692 $578,000
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $2.87 Million - $3.3 Million	-110,861 Reduced 84.14%	20,892 $579,000
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $93,832 - $121,878	-3,591 Reduced 2.65%	131,753 $3.79 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $131,440 - $153,640	4,096 Added 3.12%	135,344 $4.49 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $453,342 - $524,506	12,551 Added 10.57%	131,248 $4.81 Million
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $1.69 Million - $2.2 Million	-42,994 Reduced 26.59%	118,697 $4.84 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $99,198 - $129,492	-2,376 Reduced 1.45%	161,691 $8.29 Million
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $24,724 - $30,182	-565 Reduced 0.34%	164,067 $7.18 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $91,710 - $108,740	-1,971 Reduced 1.18%	164,632 $8.63 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $688,766 - $853,467	-15,055 Reduced 8.29%	166,603 $8.63 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $536,540 - $795,331	12,985 Added 7.7%	181,658 $10.7 Million
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $193,110 - $248,066	-4,920 Reduced 2.83%	168,673 $7.26 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $374,900 - $424,699	10,440 Added 6.4%	173,593 $6.8 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $432,690 - $487,988	-12,920 Reduced 7.34%	163,153 $5.91 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $225,822 - $287,152	-6,747 Reduced 3.69%	176,073 $6.48 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $34,925 - $40,975	1,100 Added 0.61%	182,820 $6.71 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $1.49 Million - $1.81 Million	-49,571 Reduced 21.43%	181,720 $5.94 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $54,330 - $77,626	-2,010 Reduced 0.86%	231,291 $7.55 Million
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $579,721 - $657,909	-17,610 Reduced 7.02%	233,301 $9.14 Million
Q3 2019 Oct 28, 2019	SELL	$32.49 - $42.13 $304,723 - $395,137	-9,379 Reduced 3.6%	250,911 $9.02 Million
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $3.66 Million - $4.11 Million	-99,090 Reduced 27.57%	260,290 $11.3 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $8.75 Million - $9.62 Million	-233,440 Reduced 39.38%	359,380 $15.3 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $987,024 - $1.13 Million	-25,657 Reduced 4.15%	592,820 $25.9 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $1.31 Million - $1.59 Million	38,027 Added 6.55%	618,477 $27.3 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $192,603 - $205,334	5,840 Added 1.02%	580,450 $21.1 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $829,979 - $962,890	-26,010 Reduced 4.33%	574,610 $20.4 Million
Q4 2017 Jan 29, 2018	BUY	$33.26 - $35.29 $1.56 Million - $1.65 Million	46,860 Added 8.46%	600,620 $21.8 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $1.34 Million - $1.48 Million	43,260 Added 8.47%	553,760 $19.8 Million
Q2 2017 Aug 07, 2017	BUY	N/A	510,500	510,500 $17.1 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.

Account

Twin Capital Management Inc Pfizer Inc Transaction History